Clinical management of vitreomacular traction.
Publication/Presentation Date
5-1-2015
Abstract
PURPOSE OF REVIEW: To describe recent evidence regarding the clinical management of vitreomacular traction (VMT).
RECENT FINDINGS: Recent studies have reported favorable outcomes in patients with VMT managed with observation, pharmacologic vitreolysis with ocriplasmin, and intravitreal perfluoropropane gas. Subgroup analysis has identified features associated with spontaneous release of VMT as well as features associated with successful pharmacologic release of VMT with ocriplasmin.
SUMMARY: Observation may be an appropriate initial recommendation for patients with mild VMT. When treatment is necessary, pharmacologic vitreolysis with ocriplasmin is an effective nonsurgical therapeutic option. Careful patient selection improves success rates with ocriplasmin. Further study is necessary to establish the efficacy of intravitreal perfluoropropane gas for VMT as well as the efficacy of ocriplasmin in patients with VMT and concurrent retinal disease. As these treatments are more widely used, prospective data will continue to clarify their risk/benefit profile.
Volume
26
Issue
3
First Page
143
Last Page
148
ISSN
1531-7021
Published In/Presented At
Khan, M. A., & Haller, J. A. (2015). Clinical management of vitreomacular traction. Current opinion in ophthalmology, 26(3), 143–148. https://doi.org/10.1097/ICU.0000000000000149
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
25784108
Department(s)
Administration and Leadership
Document Type
Article